Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Angiochem's EPiC platform yields anticancer drugs with improved brain penetration

April 19, 2010

Merck & Co.'s new GPR119 agonist lowers blood glucose in murine diabetes model

April 19, 2010

AZD-7295 well tolerated in HCV and active against HCV genotype 1b

April 16, 2010

Phase II data on sulopenem-based regimens for community-acquired pneumonia requiring hospitalization

April 16, 2010

Oral CoQ10 improves mitochondrial dysfunction in patients on statin therapy

April 16, 2010

Promising antisense oligonucleotide therapeutics for DMD disclosed

April 16, 2010

Panobacumab efficacious in phase IIa trial in hospital-acquired and ventilator-associated pneumonia

April 16, 2010

Clinical evaluation of oseltamivir/zanamivir combination for seasonal influenza

April 16, 2010

Oral torezolid phosphate safe in phase II trial in complicated skin/skin structure infection

April 15, 2010

Roche discloses new therapeutics for type 2 diabetes

April 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...